Literature DB >> 18685318

The changing face of patients presenting for liver transplantation.

Victor W Xia1, Masahiko Taniguchi, Randolph H Steadman.   

Abstract

PURPOSE OF REVIEW: Significant changes have been witnessed recently in patients presenting for liver transplantation. The growing number of liver transplantations performed, the increasingly successful outcomes, the expansion of indications, and the implementation of the Model for End-Stage Liver Disease (MELD) system are driving forces for those changes. The purpose of this review is to examine those changes and their effect in perioperative management. RECENT
FINDINGS: Patients who present for liver transplantation today have higher MELD scores and more advanced liver disease. Studies show that high MELD score patients are associated with high perioperative risks and undergo a more difficult perioperative course than patients with low MELD score. More specifically, they have more preoperative comorbidities, more baseline laboratory abnormalities, and higher requirements for intraoperative transfusion and vasopressors. Progress has been also made in management in patients with hepatocellular carcinoma, fulminant hepatic failure, and coronary artery disease prior to liver transplantation.
SUMMARY: Patients who present for liver transplantation today are more acutely ill compared with a few years ago and have more comorbidities, higher perioperative risks, and a more difficult perioperative course. Further characterization of the changes and associated perioperative risks and strategies to manage those risks are needed.

Entities:  

Mesh:

Year:  2008        PMID: 18685318     DOI: 10.1097/MOT.0b013e328300a070

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  20 in total

1.  Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization.

Authors:  Kent Feng; Vipul Gupta; Enrique Terrazas; Yerem Yeghiazarians; Thomas Ports; Gabriel Gregoratos; Mehdi Tavakol; John Paul Roberts; Andrew Boyle
Journal:  Am J Cardiovasc Dis       Date:  2014-10-11

Review 2.  Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes research.

Authors:  Zeeshan Butt; Neehar D Parikh; Anton I Skaro; Daniela Ladner; David Cella
Journal:  Curr Opin Organ Transplant       Date:  2012-06       Impact factor: 2.640

Review 3.  Role of cardiovascular intervention as a bridge to liver transplantation.

Authors:  Zankhana Raval; Matthew E Harinstein; James D Flaherty
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 4.  Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation.

Authors:  Kalindi Parikh; Andrew Appis; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2014-10-08       Impact factor: 5.952

5.  Early post-transplant survival: Interaction of MELD score and hospitalization status.

Authors:  Therese Bittermann; George Makar; David S Goldberg
Journal:  J Hepatol       Date:  2015-04-07       Impact factor: 25.083

6.  Storage age of transfused red blood cells during liver transplantation and its intraoperative and postoperative effects.

Authors:  Jun Chen; Terry Singhapricha; Masood Memarzadeh; Alyssa Ziman; Shan Yuan; Ke-qin Hu; Randolph H Steadman; Ronald W Busuttil; Victor W Xia
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

7.  SPECT myocardial perfusion imaging in liver transplantation candidates.

Authors:  W Lane Duvall; Aditi Singhvi; Nidhi Tripathi; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2018-08-23       Impact factor: 5.952

8.  Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.

Authors:  Lisa B VanWagner; Matthew E Harinstein; James R Runo; Christopher Darling; Marina Serper; Shelley Hall; Jon A Kobashigawa; Laura L Hammel
Journal:  Am J Transplant       Date:  2017-11-18       Impact factor: 8.086

9.  The liver transplant risk score prognosticates the outcomes of liver transplant recipients at listing.

Authors:  Christof Kaltenmeier; Dana Jorgensen; Stalin Dharmayan; Subhashini Ayloo; Vikrant Rachakonda; David A Geller; Samer Tohme; Michele Molinari
Journal:  HPB (Oxford)       Date:  2020-11-11       Impact factor: 3.647

10.  Sluggish decline in a post-transplant model for end-stage liver disease score is a predictor of mortality in living donor liver transplantation.

Authors:  Won Jung Hwang; Joon Pyo Jeon; Seung Hee Kang; Hyun Sik Chung; Ji Yong Kim; Chul Soo Park
Journal:  Korean J Anesthesiol       Date:  2010-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.